Sophie Vandebroek V - 17 Feb 2026 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Sophie V. Vandebroek
Issuer symbol
IDXX
Transactions as of
17 Feb 2026
Net transactions value
-$604,758
Form type
4
Filing time
19 Feb 2026, 18:00:21 UTC
Previous filing
13 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Vandebroek Sophie V. Director ONE IDEXX DRIVE, WESTBROOK /s/ Lily J. Lu, Attorney-in-Fact for Sophie V. Vandebroek 19 Feb 2026 0001442078

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $315,536 +945 +81% $333.90 2,112 17 Feb 2026 Direct
transaction IDXX Common Stock Sale $594,070 -945 -45% $628.65 1,167 17 Feb 2026 Direct
transaction IDXX Common Stock Sale $326,223 -519 -44% $628.56 648 17 Feb 2026 Direct
holding IDXX Common Stock 8,173 17 Feb 2026 By Sophie V. Vandebroek Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -945 -100% 0 17 Feb 2026 Common Stock 945 $333.90 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of stockholders, whichever event was earlier.
F2 Not applicable